JLE

Epileptic Disorders

MENU

GAD65-Ab encephalitis and subtle focal status epilepticus Volume 21, issue 5, October 2019

  • [Brenner et al., 2013] Brenner T., Sills G.J., Hart Y. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia. 2013;54:1028-1035. 6
  • [Chang et al., 2013] Chang T., Alexopoulos H., McMenamin M. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome. JAMA Neurol. 2013;70:1140-1149. 9
  • [Daif et al., 2018] Daif A., Lukas R.V., Issa N.P. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav. 2018;80:331-336.
  • [Falip et al., 2012] Falip M., Carreño M., Miró J. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol. 2012;19:827-833. 6
  • [Gagnon and Savard, 2016] Gagnon M.-M., Savard M. Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci. 2016;43:486-493. 4
  • [Gaspard, 2016] Gaspard N. Autoimmune epilepsy. Continuum (Minneap Minn). 2016;22:227-245. 1
  • [Graus et al., 2016] Graus F., Titulaer M.J., Balu R. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391-404. 4
  • [Honnorat et al., 2001] Honnorat J., Saiz A., Giometto B. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58:225-230. 2
  • [Malter et al., 2010] Malter M.P., Helmstaedter C., Urbach H. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67:470-478. 4
  • [Najjar et al., 2011] Najjar S., Pearlman D., Najjar J. Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity? Epilepsy Behav. 2011;21:306-313. 3
  • [Saiz et al., 2008] Saiz A., Blanco Y., Sabater L. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131:2553-2563. 10
  • [Serafini et al., 2016] Serafini A., Lukas R.V., VanHaerents S. Paraneoplastic epilepsy. Epilepsy Behav. 2016;61:51-58.
  • [Vinke et al., 2018] Vinke A.M., Schaper FLWVJ, Vlooswijk M.C.G. Anti-GAD antibodies in a cohort of neuropsychiatric patients. Epilepsy Behav. 2018;82:25-28.